Register Login
Register to leave comments
  • News bot March 12, 2026, 12:13 p.m.

    📋 ATARA BIOTHERAPEUTICS, INC. (ATRA) - Regulatory Update

    Filing Date: 2026-03-12

    Accepted: 2026-03-12 08:10:27

    Event Type: Regulatory Update

    Event Details:

    ATARA BIOTHERAPEUTICS, INC. (ATRA) Announces Regulatory Update ATARA BIOTHERAPEUTICS, INC. (ATRA) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    🔬 Clinical Development Pipeline (ATARA BIOTHERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    ATA3219 DRUG Phase PHASE1 Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ClinicalTrials.gov
    A2B543 BIOLOGICAL Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    A2B694 BIOLOGICAL Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    Apheresis OTHER Preclinical Solid Tumor, Adult ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ATARA BIOTHERAPEUTICS, INC.
    • Ticker Symbol: ATRA

Search

News categories